We conclude that the DNA methylation in the CEBPA distal promoter region correlates at least in part with the downregulation of CEBPA expression in CN-AML patients and that also other causes for DNA methylation must be considered. The gene discussed is CEBPA; the disease is acute myeloid leukemia.